We are live on ! Find out more
PAI

Pittenger & Anderson Inc Portfolio holdings

AUM $2.79B
1-Year Est. Return 12.81%
This Fund
S&P 500
This Quarter Est. Return
-1.83%
1 Year Est. Return
+12.81%
3 Year Est. Return
+63.36%
5 Year Est. Return
+74.7%
10 Year Est. Return
+316.53%
AUM
$2.6B
AUM Growth
-$128M
Cap. Flow
+$28.1M
Cap. Flow %
1.08%
Top 10 Hldgs %
31.63%
Holding
528
New
72
Increased
142
Reduced
99
Closed
20

Top Buys

Rank Stock Value
1
CSX icon
CSX Corp
CSX
+$11M
2
NVDA icon
NVIDIA
NVDA
+$8.56M
3
FBND icon
Fidelity Total Bond ETF
FBND
+$3.79M
4
PM icon
Philip Morris
PM
+$3.47M
5
CRWD icon
CrowdStrike
CRWD
+$3.33M

Sector Composition

Rank Sector Weight
1 Technology 22.45%
2 Financials 13.9%
3 Industrials 8.73%
4 Consumer Discretionary 5.98%
5 Healthcare 5.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHD icon
76
Schwab US Dividend Equity ETF
SCHD
$103B
$8.35M 0.32%
304,340
-20,663
-6% -$562K
GS icon
77
Goldman Sachs
GS
$300B
$8.22M 0.32%
9,348
+231
+3% +$188K
VOT icon
78
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.2B
$8.03M 0.31%
28,760
-220
-0.8% -$63K
ZTS icon
79
Zoetis
ZTS
$32.4B
$7.59M 0.29%
60,290
-26,124
-30% -$3.41M
VOE icon
80
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
$7.52M 0.29%
42,399
-125
-0.3% -$21.9K
DOV icon
81
Dover
DOV
$27.6B
$7.25M 0.28%
37,145
IDXX icon
82
Idexx Laboratories
IDXX
$44.1B
$7.1M 0.27%
10,491
+43
+0.4% +$29.3K
LYV icon
83
Live Nation Entertainment
LYV
$40.6B
$6.94M 0.27%
48,691
+415
+0.9% +$59.6K
ABBV icon
84
AbbVie
ABBV
$443B
$6.82M 0.26%
29,832
+1,110
+4% +$253K
SHW icon
85
Sherwin-Williams
SHW
$82.7B
$6.77M 0.26%
20,900
-1,511
-7% -$505K
NVS icon
86
Novartis
NVS
$297B
$6.76M 0.26%
49,020
AIZ icon
87
Assurant
AIZ
$13.8B
$6.6M 0.25%
27,385
MCD icon
88
McDonald's
MCD
$192B
$6.57M 0.25%
21,487
+3,866
+22% +$1.18M
XOM icon
89
ExxonMobil
XOM
$644B
$6.34M 0.24%
52,683
+19,941
+61% +$2.31M
MELI icon
90
Mercado Libre
MELI
$95.2B
$6.26M 0.24%
3,110
+395
+15% +$830K
SHOP icon
91
Shopify
SHOP
$152B
$6.24M 0.24%
38,780
-5,030
-11% -$808K
FBND icon
92
Fidelity Total Bond ETF
FBND
$26.9B
$6.2M 0.24%
134,703
+81,665
+154% +$3.79M
CVX icon
93
Chevron
CVX
$392B
$6.04M 0.23%
39,605
+17,685
+81% +$2.69M
AZN icon
94
AstraZeneca
AZN
$263B
$5.97M 0.23%
32,460
+150
+0.5% +$26.3K
IJJ icon
95
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.83B
$5.88M 0.23%
44,662
+272
+0.6% +$35.4K
PM icon
96
Philip Morris
PM
$297B
$5.76M 0.22%
35,896
+22,378
+166% +$3.47M
UBER icon
97
Uber
UBER
$143B
$5.69M 0.22%
69,619
+24,601
+55% +$2.22M
SCHW
98
Charles Schwab
SCHW
$183B
$5.69M 0.22%
56,917
+1,370
+2% +$130K
INTU icon
99
Intuit
INTU
$86.5B
$5.58M 0.21%
8,429
+542
+7% +$358K
ALLE icon
100
Allegion
ALLE
$13.4B
$5.56M 0.21%
34,940

Similar funds

Pittenger & Anderson Inc's Q4 2025 Portfolio in Review

As of Q4 2025, Pittenger & Anderson Inc held 528 positions worth $2.6B, down 4.7% from $2.73B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Pittenger & Anderson Inc's Q4 2025 filing shows 72 new, 142 increased, 99 reduced and 20 closed positions. Its largest new stake was Solstice Advanced Materials: 30,417 shares worth $1.48M. The largest sale was Arista Networks, an estimated $9.82M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 29% a quarter earlier, followed by Financials and Industrials.

  • Pittenger & Anderson Inc's largest Q4 2025 buy was Solstice Advanced Materials: 30,417 shares worth $1.48M.
  • Pittenger & Anderson Inc added most to CSX Corp in Q4 2025, an estimated $11M increase.
  • Pittenger & Anderson Inc's biggest Q4 2025 reduction was Arista Networks, cutting an estimated $9.82M.
  • Pittenger & Anderson Inc fully exited Motorola Solutions in Q4 2025, selling an estimated $2.83M.
  • Pittenger & Anderson Inc's ten largest holdings make up 32% of its $2.6B portfolio in Q4 2025.
  • Pittenger & Anderson Inc opened 72 new positions and closed 20 in Q4 2025.
  • Pittenger & Anderson Inc's portfolio value fell 4.7% quarter-over-quarter to $2.6B.

Based on Pittenger & Anderson Inc's 13F filing for Q4 2025, filed 2 Feb 2026.